Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind trial of serum-free Vero cell rabies vaccine using 4-dose or 5-dose regimens in people aged 10 to 60 years
CTR20232265Phase 3Completed
- Sponsor
- Ningbo Rongan Biological Pharmaceutical Co., Ltd.
- Start
- Aug 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of rabies vaccine (serum-free vero cell) for human use, freeze-dried in rabies, sponsored by Ningbo Rongan Biological Pharmaceutical Co., Ltd.. Started Aug 2023; status: completed.
02
Drugs
rabies vaccine (serum-free vero cell) for human use, freeze-dried
03
Conditions
rabies
Beyond the preview
Go deeper on CTR20232265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232265.